Clinical trial
Morphine or Fentanyl for Refractory Dyspnea in COPD
NCT03834363 is registered in ClinicalTrials.gov with Huib A.M. Kerstjens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Morphine or Fentanyl for Refractory Dyspnea in COPD
- Lead sponsor
- Huib A.M. Kerstjens
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 15, 2019
- Completion date
- August 24, 2024
- Enrollment
- 59 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
copd